Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03608033 |
|
Recruitment Status :
Recruiting
First Posted : July 31, 2018
Last Update Posted : May 30, 2019
|
Sponsor:
Omeros Corporation
Information provided by (Responsible Party):
Omeros Corporation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2020 |
| Estimated Study Completion Date : | April 2023 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):